PATENT CLAIM ANALYSIS

Application Number: 15972966
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "230500"]

Abstract:
Chemical entities of Formula (I): Including enantiomers thereof, wherein R 1  has any of the values described herein, and compositions comprising such chemical entities; their preparation; and their use in various methods, including the treatment of depression, pain, cognitive disorders, neurodegenerative disorders, and other neurological and peripheral disorders.

Claim (Index 6):
The method of  claim 4 , wherein the depressive disorder is treatment-refractory depression or treatment-resistant depression.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.38636
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15253645', '14279716', '14991786', '14445498', '14199844']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7566649691552968
- 35 USC 102 Novelty (BERT): 0.5469845157718296
- Combined Prediction Score: 0.7356969238169502
- Mean Citation Score: 292.5404000000001
- Max Citation Score: 398.32794
- Similarity Product: 200.3843425841009

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test